ABCG2 and non-small cell lung carcinoma: For example, a study conducted by Hata et al. compared the safety of ABCP with that of the BCP combination for treating advanced non-squamous (NSQ)-NSCLC in Japanese patients, observing higher incidences of FN in the ABCP group [23].